OXR1 and Parkinson disease: The Parkinson’s and ALS mouse models further demonstrate that increasing OXR1 expression alleviates physical symptoms associated with neurodegeneration (Liu et al., 2015; Li et al., 2017; Jiang et al., 2019; Williamson et al., 2019).